<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is associated with several human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>A variety of cytokines and receptors have been described to be activated by EBV </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that the IL-2 receptor (IL-2R) alpha-chain, which is weakly expressed on <z:mpath ids='MPATH_458'>normal</z:mpath> resting lymphoid cells, is activated by EBV </plain></SENT>
<SENT sid="3" pm="."><plain>Comparison of EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines and their EBV convertants showed an enhanced CD25 expression in EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Transient expression of the oncogenic virus protein latent membrane protein-1 (LMP1) in L428 Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells and in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells (BL2, BL41, BL30) cells leads to enhanced CD25 expression </plain></SENT>
<SENT sid="5" pm="."><plain>Both C-terminal activating regions (CTARs) of LMP1 are involved in CD25 activation </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibition of LMP1-mediated NFkappaB enhancement by a constitutive repressive form of IkappaB-alpha resulted in decreased CD25 surface expression, indicating that NFkappaB is involved in CD25 gene regulation </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, LMP1-mediated CD25 activation was associated with enhanced levels of the soluble form of CD25 (sCD25) in L428 Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells but not in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>LMP1 associated enhanced expression of membrane CD25 and soluble CD25 may have immunomodulatory functions and could be involved in biology of EBV-associated diseases </plain></SENT>
</text></document>